Stockreport

NLS Pharmaceutics Announces Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists (DOXA) [Yahoo! Finance]

NLS Pharmaceutics Ltd. - Common Shares  (NLSP) 
PDF biopharmaceutical company dedicated to pioneering therapies for rare and complex central nervous system disorders, today announced the publication of the latest patent a [Read more]